Symptomatology, pathophysiology and treatment perspectives of "long COVID" syndrome
The year 2020 was marked in history by the pandemic of SARS-CoV-2 infection. The relatively quick introduction of vaccinations and antiviral drugs (e.g. orally administered molnupiravir, nirmatrelvir/ritonavir) allowed the global nature of COVID-19 to be controlled after more than 2 years. Currently...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | |
| Опубликовано: |
Polish Pharmaceutical Society,
2024-04-01T00:00:00Z.
|
| Предметы: | |
| Online-ссылка: | Connect to this object online. |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Internet
Connect to this object online.3rd Floor Main Library
| Шифр: |
A1234.567 |
|---|---|
| Копировать 1 | Доступно |